CRISPR Therapeutics AG CRSP Balance Sheet (2015-2026)

NASDAQ CRSP
$56.00 +1.91 (+3.53%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

CRISPR Therapeutics AG Quarterly Balance Sheet

Periods 44 quarters
Latest Jun 2026

CRISPR Therapeutics AG reported total assets of $2650.77M and total liabilities of $904.22M for the quarter ended Jun 2026, up 30.6% year over year. This balance sheet covers 44 quarters of results from Sep 2015 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Accumulated Depreciation
32.83M37.81M43.83M51.09M27.97M33.83M38.87M43.82M48.55M53.43M58.25M63.07M67.79M72.27M76.97M81.60M85.61M91.05M95.34M99.59M
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
1,011.55M923.03M683.91M496.89M494.15M211.88M344.41M444.80M527.76M389.48M707.43M484.47M225.67M298.30M235.18M193.62M286.50M347.56M423.31M291.34M
Receivables - NetNet Receivables
0.15M0.30M0.14M0.07M0.05M70.00M200.00M25.00M
Receivables - OtherOther Receivables
8.40M11.20M6.50M2.10M
Receivables
0.15M8.71M0.14M0.07M0.05M11.20M70.00M206.50M27.10M
Prepaid Assets
41.42M38.08M39.21M41.65M36.68M37.71M24.80M21.47M20.76M14.39M11.50M8.79M8.25M8.31M12.33M12.43M13.38M9.84M6.58M7.42M
Current Assets
2,518.93M2,417.51M2,260.62M2,107.06M1,932.70M1,853.03M1,907.97M1,859.57M1,760.59M1,908.08M2,119.62M2,010.41M1,943.89M1,937.13M1,867.61M1,733.67M1,929.09M1,985.67M2,448.36M2,371.77M
Non-Current Assets
Property, Plant & Equipment (Net)
105.88M137.57M157.45M165.19M166.11M163.63M162.20M159.17M156.12M151.94M147.25M143.03M138.54M134.09M129.43M124.93M120.83M115.85M112.17M108.07M
Long-Term Investments
8.40M77.15M53.13M6.32M4.90M2.00M11.22M28.41M
Intangibles
0.14M0.12M0.11M0.10M0.08M0.07M0.06M0.04M0.03M0.02M0.00M
Goodwill & Intangibles
0.14M0.12M0.11M0.10M0.08M0.07M0.06M0.04M0.03M0.02M0.00M
Other Non-Current Assets
16.85M16.91M12.12M12.12M12.12M11.63M11.72M11.80M11.83M11.59M11.52M11.52M11.52M15.83M8.01M8.01M24.31M24.37M28.98M37.71M
Non-Current Assets
302.79M334.36M345.56M356.31M420.65M390.03M336.40M337.44M326.24M321.49M319.39M329.45M312.24M304.90M298.49M296.05M316.22M279.57M277.46M279.00M
Assets
2,821.72M2,751.88M2,606.18M2,463.36M2,353.36M2,243.06M2,244.36M2,197.01M2,086.83M2,229.57M2,439.02M2,339.85M2,256.13M2,242.03M2,166.10M2,029.71M2,245.31M2,265.24M2,725.82M2,650.77M
Liabilities
Current Liabilities
Accounts Payables
10.17M14.82M27.11M25.24M32.11M27.43M45.15M27.59M26.15M38.15M16.46M9.45M15.58M14.71M13.06M9.75M11.80M11.14M13.65M11.31M
Payables
10.17M14.82M27.11M25.24M32.11M27.43M45.15M27.59M26.15M38.15M16.46M9.45M15.58M14.71M13.06M9.75M11.80M11.14M13.65M11.31M
Accumulated Expenses
68.30M91.00M72.63M82.22M102.95M77.68M85.63M89.84M66.41M45.34M76.43M91.88M47.20M41.07M84.61M73.74M84.18M89.41M74.93M70.28M
Other Accumulated Expenses
0.33M1.26M2.27M2.48M0.73M1.16M1.06M1.16M0.83M5.14M4.82M4.82M4.82M10.42M0.46M0.60M0.56M13.11M13.11M16.98M
Current Taxes
3.27M0.72M2.61M3.95M4.27M0.14M0.27M0.56M0.18M0.44M1.21M0.45M0.84M0.45M1.24M0.71M3.43M1.11M0.64M0.49M
Current Deferred Revenue
1.56M1.01M3.50M4.11M4.07M4.76M4.48M3.85M3.02M2.13M1.29M15.77M15.34M15.19M
Total Current Liabilities
96.21M119.88M113.70M119.96M150.87M121.11M146.79M132.84M111.23M108.79M118.99M127.82M89.81M87.78M119.45M104.36M118.96M149.12M136.29M132.90M
Non-Current Liabilities
Convertible Debt
Non-Current Deffered Revenue
11.78M12.32M12.32M12.32M12.32M12.32M12.32M12.32M15.82M14.01M13.54M12.58M12.32M12.32M12.32M12.32M12.32M
Preferred Stock Liabilities
Minority Interest
Operating Leases
192.73M212.87M227.90M234.16M230.90M228.18M224.55M230.34M226.59M223.01M218.94M214.85M210.66M206.41M201.85M197.43M192.77M188.17M183.56M178.90M
Other Non-Current Liabilities
8.09M7.34M7.33M6.09M5.31M5.97M5.80M5.48M5.39M0.96M3.62M3.65M3.68M3.44M3.32M4.48M5.28M6.14M5.95M6.22M
Total Non-Current Liabilities
300.72M345.08M353.92M366.44M394.09M361.61M383.67M375.50M353.64M345.81M351.47M355.26M312.80M306.51M333.62M314.11M324.05M337.29M905.32M898.00M
Total Liabilities
308.80M352.42M361.26M372.53M399.40M367.58M389.47M380.99M359.04M346.77M355.08M358.90M316.47M309.95M336.94M318.59M329.33M343.43M911.26M904.22M
Shareholder's Equity
Common Equity
2,512.92M2,399.46M2,244.92M2,090.83M1,953.95M1,875.48M1,854.90M1,816.03M1,727.79M1,882.80M2,083.94M1,980.95M1,939.66M1,932.08M1,829.16M1,711.12M1,915.98M1,921.81M1,814.56M1,746.55M
Liabilities and Shareholders Equity
2,821.72M2,751.88M2,606.18M2,463.36M2,353.36M2,243.06M2,244.36M2,197.01M2,086.83M2,229.57M2,439.02M2,339.85M2,256.13M2,242.03M2,166.10M2,029.71M2,245.31M2,265.24M2,725.82M2,650.77M
Treasury Shares
0.18M0.18M0.18M0.18M0.18M0.18M0.18M0.18M0.18M0.17M0.17M0.17M0.17M0.17M0.17M0.17M0.13M0.12M0.12M0.10M
Retained Earnings
-54.67M-195.91M-375.13M-560.97M-735.51M-846.09M-899.15M-976.89M-1089.05M-999.70M-1116.29M-1242.70M-1328.64M-1365.95M-1501.95M-1710.50M-1816.94M-1947.55M-2070.48M-2161.64M

CRISPR Therapeutics AG Balance Sheet API

Pull CRISPR Therapeutics AG's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CRSP&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY